Rayner announces full commercial availability of spiral IOLs RayOne Galaxy and RayOne Galaxy Toric

Image credit: Rayner

Rayner has announced the full commercial release of RayOne Galaxy and RayOne Galaxy Toric, the company’s spiral IOL product.¹ The IOLs were first unveiled in September 2024 at the European Society of Cataract and Refractive Surgeons (ESCRS) congress in Barcelona, Spain and were previously available to selective surgeon between October and December 2024 in a limited release phase, according to a news release.

“With over 6000 lenses now in the market, we want to thank everyone who has placed their trust in our new lens technology,” said Tim Clover, Rayner CEO, in the release. “The response and enthusiasm from our customers around the world has been phenomenal and we look forward to seeing more patients achieving excellent results with the world’s first spiral IOL.”

The IOLs are equipped with a non-diffractive spiral optic, developed by artificial intelligence (AI), which allows for a full range of vision with minimized dysphotopsia and 0% loss of transmitted light.¹

A total of 10 leadings surgeons from 10 countries conducted a pre-launch clinical evaluation, involving over 180 that were treated with both RayOne Galaxy IOLs. Postoperative clinical outcomes at 1 and 3 months were collected, with both a full range of vision and less halo and glare reported in the evaluation. The vision range was without a wave-like defocus pattern that is often associated with diffractive trifocal IOLs, with mean corrected and uncorrected visual acuities at all distances of 0.1 logMAR or better, and binocular defocus curve VA of 0.2 logMAR or better across a ~4.0D range. Additionally, in a pre-clinical study of 30 subjects with health eyes, RayOne Galaxy demonstrated a halo size closer to that of an enhanced monofocal IOL.¹

“I have had the opportunity to implant RayOne Galaxy during Rayner’s prelaunch clinical phase, and it was immediately apparent that this IOL can provide a very long range of focus with minimal compromises on the quality of night vision,” said Francesco Carones, MD, who took part in the initial clinical evaluation, in the release. “I think this IOL represents a significant step forward in the technologies available to provide patients with very reduced spectacle dependence following lens replacement for cataract or refractive purposes.”

Reference:

1. Rayner announces full release of RayOne Galaxy spiral IOL. News release. January 15, 2025. Accessed January 22, 2025. https://rayner.com/global/galaxy-full-release-news/